A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2011
11/30/2011	CN101716161B 一种胸腺肽壳聚糖微球口服药物制剂及其制备方法 Chitosan microspheres oral pharmaceutical formulation and preparation of thymosin
11/30/2011	CN101700290B 一种防治畜禽温热病药物组合物及其制备方法 A pharmaceutical composition of livestock warm disease prevention and preparation method
11/30/2011	CN101671638B 一种双歧杆菌新菌株及其发酵制备方法与应用 One kind of Bifidobacterium strains and fermentation new preparation method and application
11/30/2011	CN101638444B 海滨锦葵多糖制备工艺及用途 Virginica polysaccharide preparation and use
11/30/2011	CN101638431B 能与NKp80 受体结合的多肽及其应用 With NKp80 receptor binding polypeptides and their Applications
11/30/2011	CN101632663B 神经毒性的分子靶 Molecular targets neurotoxicity
11/30/2011	CN101580551B 关玉竹多糖的提取方法 Extraction of polysaccharides off Yuzhu
11/30/2011	CN101549047B 五行养生胶囊 Five health capsules
11/30/2011	CN101503727B 三角帆蚌酶解多肽及其制备和应用 Cumingii enzymatic peptides and their preparation and use
11/30/2011	CN101417008B 作为中兽药复方制剂的注射用双黄连及其制备工艺与应用 SHL injection technology and application in veterinary medicine and its preparation as a compound preparation
11/30/2011	CN101311191B 抗人淋巴细胞免疫球蛋白的制备方法 Anti-human lymphocyte immune globulin preparation
11/30/2011	CN101305777B 银杏果肉酱 Ginkgo fruit sauce
11/30/2011	CN101301075B 一种含韭菜籽增强免疫力功能性食品及其制备方法 Leek seeds containing enhanced immunity functional food and its preparation method
11/30/2011	CN101194906B 一种用于治疗过敏性疾病的滴丸及其制备方法 Dropping Pills and its preparation method for the treatment of allergic diseases
11/29/2011	US8067575 RNA interference mediated inhibition of cyclin D1 gene expression using short interfering nucleic acid (siNA)
11/29/2011	US8067569 Splice-region antisense composition and method
11/29/2011	US8067564 Methods of obtaining a specific binding member that binds eotaxin
11/29/2011	US8067437 Beta-2-adrenoreceptor agonists
11/29/2011	US8067426 6-amino-purin-8-one compounds
11/29/2011	US8067413 9-substituted-8-oxo-adenine compounds as toll-like receptor (TLR7 ) modulators
11/29/2011	US8067411 Compounds
11/29/2011	US8067396 Amino alcohol compounds or phosphonic acid derivatives thereof
11/29/2011	US8067373 Therapeutic fibrin-derived peptides and uses thereof
11/29/2011	US8067361 Chaperonin 10 immunosuppression
11/29/2011	US8067247 Use of anti-CD100 antibodies for the treatment of inflammatory disorders affecting the central or peripheral nervous system
11/29/2011	US8067228 Nucleic acid compositions and their use against the hepatitic C virus
11/29/2011	US8067030 Controlled release composition and method of producing the same
11/29/2011	US8067001 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/29/2011	CA2672000C Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of lymphoma
11/29/2011	CA2636826C Thiazoles as 11 beta-hsd1 inhibitors
11/29/2011	CA2579032C Use of an .delta.-amino acid as thymocyte growth agent
11/29/2011	CA2526022C Sulfotransferase inhibitor
11/29/2011	CA2507502C Inhibition of inflammation using alpha 7 receptor-binding cholinergic agonists
11/29/2011	CA2486910C Ophthalmological use of roflumilast for the treatment of diseases of the eye
11/29/2011	CA2473634C 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
11/29/2011	CA2465757C Triazole derivatives as cyclooxygenase (cox) inhibitors
11/29/2011	CA2438524C Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors
11/29/2011	CA2414331C Pd-l2 molecules: novel pd-1 ligands and uses therefor
11/29/2011	CA2366541C Novel recombinant and mutant herpesviruses
11/24/2011	WO2011146574A1 Il-12 formulations for enhancing hematopoiesis
11/24/2011	WO2011146395A2 Prevention of immunological rejection of transplanted stem cells by leukocyte costimulatory molecule blockade
11/24/2011	WO2011144924A1 Amine or amid analogues of sanglifehrin
11/24/2011	WO2011144585A1 Pyrrolo [2, 3 - b] pyrazine - 7 - carboxamide derivatives and their use as jak and syk inhibitors
11/24/2011	WO2011144584A1 Pyrrolopyrazine derivatives as syk and jak inhibitors
11/24/2011	WO2011144501A1 Ccr2 antagonists and uses thereof
11/24/2011	WO2011144338A1 Pyrazole derivatives as s1p1 agonists
11/24/2011	WO2011120135A8 Antibodies with enhanced or suppressed effector function
11/24/2011	WO2011120134A8 Antibodies with enhanced or suppressed effector function
11/24/2011	WO2011109833A3 Induced dendritic cell compositions and uses thereof
11/24/2011	WO2011097581A9 THE USE OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) AND PACAP ANALOGS AS ADJUNCTIVE TREATMENTS WITH INHIBITORS OF CALCINEURIN OR INHIBITORS OF THE MAMMALIAN TARGET OF RAPAMYCIN (mTOR) COMPLEXES
11/24/2011	WO2011056056A3 Anti-cytokine vhnar domains
11/24/2011	US20110289608 Antisense modulation of interleukins 17 and 23 signaling
11/24/2011	US20110289606 Equine disease model for herpesvirus neurologic disease and uses thereof
11/24/2011	US20110288275 Modified Proteins, Designer Toxins, and Methods of Making Thereof
11/24/2011	US20110288176 Ethacrynic acid-containing composition for prevention or treatment of transglutaminase-related diseases and method for prevention or treatment of transglutaminase-related diseases using the same
11/24/2011	US20110288166 Triptolide c-ring derivatives as anticancer agents and immune modulators
11/24/2011	US20110288158 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
11/24/2011	US20110288156 Nucleic Acids, Polypetides, and Methods for Modulating Apoptosis
11/24/2011	US20110288147 Compositions and methods for the specific inhibition of gene expression by DSRNA containing a tetraloop
11/24/2011	US20110288129 Amide derivatives as trpv1 antagonists
11/24/2011	US20110288127 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
11/24/2011	US20110288116 Iap inhibitors
11/24/2011	US20110288109 New compounds
11/24/2011	US20110288097 Pyrrolopyrazine Kinase Inhibitors
11/24/2011	US20110288095 Thiophene-carboxamides useful as inhibitors of protein kinases
11/24/2011	US20110288094 1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity
11/24/2011	US20110288083 Method of treating cancer by inhibition of protein kinase-like endoplasmic reticulum protein kinase
11/24/2011	US20110288073 Alpha-Aminocyclolactam Ligands for G-protein Coupled Receptors, and Methods of Using Same
11/24/2011	US20110288068 Aza spiro alkane derivatives as inhibitors of metalloproteases
11/24/2011	US20110288067 Pyrrolopyrazine Kinase Inhibitors
11/24/2011	US20110288060 apparatus and process for producing crystals
11/24/2011	US20110288038 Hesperidin-containing composition
11/24/2011	US20110288037 Pharmaceutical Composition for the Treatment of Pathologies Caused by the General Response of the Immune System
11/24/2011	US20110288025 Biopolymer produced by fermenting the extract of soybean with folic acid and a composition containing thereof
11/24/2011	US20110288017 Apo-lipoprotein propeptide
11/24/2011	US20110288004 Viral Sequences and Uses Thereof
11/24/2011	US20110287111 Substituted 6-(2-aminobenzylamino)purine derivatives, their use as medicaments and preparations containing these compounds
11/24/2011	US20110287103 Sustained-release formulations of topiramate
11/24/2011	US20110287089 Use of a saccharomyces cerevisiae mitochondrial nucleic acids fraction for immune stimulation
11/24/2011	US20110287087 Modified cationic liposome adjuvans
11/24/2011	US20110287067 Reinforced adhesive complex coacervates and methods of making and using thereof
11/24/2011	US20110287063 Methods for prevention and treatment of inflammation using anti-chemokine antibodies
11/24/2011	US20110287059 Honey analysis
11/24/2011	US20110287058 Universal GM-CSF Expressing Bystander Human Cell Line
11/24/2011	US20110287056 Agents and methods to elicit anti-tumor immune response
11/24/2011	US20110287055 Compositions comprising prfa* mutant listeria and mehtods of use thereof
11/24/2011	US20110287053 Recombinant Foot and Mouth Disease Vaccine
11/24/2011	US20110287051 Parapoxvirus vectors
11/24/2011	US20110287050 Recombinant koi herpesvirus (khv) or cyprinid herpesvirus 3 (cyhv-3) and a vaccine for the prevention of a disease caused by khv/cyhv-3 in cyprinus carpio carpio or cyprinus carpio koi
11/24/2011	US20110287049 Prevention and treatment of amyloidogenic diseases
11/24/2011	US20110287047 Cross-beta structures as carrier in vaccines
11/24/2011	US20110287046 Modified streptococcus pneumonia pneumolysin (ply) polypeptides
11/24/2011	US20110287045 Enhanced immune response against infections
11/24/2011	US20110287041 Aldehyde Tags, Uses Thereof in Site-Specific Protein Modification
11/24/2011	US20110287040 Materials and methods for treatment of inflammation
11/24/2011	US20110287037 Microorganisms as carriers of nucleotide sequences coding for antigens and protein toxins, process of manufacturing and uses thereof
11/24/2011	US20110287032 Novel ctla4-ig immunoadhesins
11/24/2011	US20110287031 Covalently reactive transition state analogs and methods of use thereof
11/24/2011	US20110287017 Anti-p-selectin antibodies and methods of their use and identification
11/24/2011	US20110287005 Monoclonal antibodies against amyloid beta protein and uses thereof

1 ... 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 ... 1172